PHASIX MESH
Received May 8, 2026 · Event occurred Mar 27, 2026
Report 1213643-2026-00605 · MDR key 25123101
Device
Generic name
Surgical Mesh
Manufacturer
Davol Inc., Sub. C.r. Bard, Inc. -1213643Model number
NACatalog number
1192030
Lot number
HUKN1456
Product problems
- Patient-Device Incompatibility
Patient
66 YR · Female
- Seroma
Narrative
Additional Manufacturer Narrative
AS REPORTED, THE SUBJECT PATIENT WAS DIAGNOSED WITH A SEROMA POST IMPLANT OF PHASIX MESH AS AN ONLAY. THE CLINICIAN HAS ASSESSED THE PATIENT'S POSTOPERATIVE SEROMA AS POSSIBLY RELATED TO THE STUDY DEVICE AND PROBABLY RELATED TO THE PROCEDURE. HOWEVER, BASED ON THE INFORMATION PROVIDED, THE EXTENT TO WHICH THE PHASIX MESH IMPLANT USED TO TREAT THE PATIENT MAY HAVE CAUSED OR CONTRIBUTED TO THE REPORTED PATIENT'S POSTOPERATIVE SEROMA CANNOT BE DETERMINED. HENCE, NO CONCLUSIONS CAN BE MADE. SEROMA FORMATION IS A CLINICALLY UNDERSTOOD POTENTIAL COMPLICATION OF SURGERY/USE OF THE DEVICE AND IS IDENTIFIED IN THE INSTRUCTIONS-FOR-USE PROVIDED WITH THE DEVICE, AS A POSSIBLE COMPLICATION. A REVIEW OF MANUFACTURING RECORDS WAS PERFORMED AND FOUND THAT THE DEVICE WAS MANUFACTURED TO SPECIFICATION. NOTE: SECTION A THROUGH F - THE INFORMATION PROVIDED BY BD REPRESENTS ALL OF THE KNOWN INFORMATION AT THIS TIME. DESPITE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL INFORMATION, THE COMPLAINANT / REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO BD.
Description of Event or Problem
AS REPORTED PER CLINICAL TRIAL (B)(4): THE SUBJECT PATIENT WAS ADMITTED TO THE HOSPITAL ON (B)(6) 2026 AND UNDERWENT AN OPEN PRIMARY LAPAROTOMY, EXPLORATORY LAPAROTOMY AND COLECTOMY DURING WHICH A PHASIX FLAT MESH ONLAY WAS PLACED AND SECURED IN PLACE WITH ABSORBABLE MONOFILAMENT SUTURES WITH 2-0 PDS. THE SURGERY WAS DONE WITH TRIMMING THE PHASIX MESH (30 CM LENGTH AND 7 CM WIDTH). THE MIDLINE FASCIA WAS COMPLETELY CLOSED WITH ETHICON SLOW ABSORBING MONOFILAMENT WITH RUNNING STITCHES APPROXIMATELY 1 CM FAR APART AND 63 CM IN LENGTH. PATIENT WAS DISCHARGED FROM THE HOSPITAL ON (B)(6) 2026. ON (B)(6) 2026, THE SUBJECT PATIENT DEVELOPED A SEROMA ON INCISION SITE, NO TREATMENT OR MEDICATION REQUIRED. THE SEROMA IS REPORTED AS RECOVERING AND RESOLVING. THE REPORTED ADVERSE EVENT (SEROMA) HAS BEEN ASSESSED PER CLINICIANS AS POSSIBLY RELATED TO THE STUDY DEVICE AND A PROBABLE RELATIONSHIP TO THE PROCEDURE. IT HAS BEEN ASSESSED AS MILD IN SEVERITY AND RECOVERING AND RESOLVING; THE REPORTED AE DOES NOT MEET THE DEFINITION OF A SAE (SERIOUS ADVERSE EVENT) AND THE DEFINITION OF USADE (UNANTICIPATED SERIOUS ADVERSE DEVICE EVENT).